查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1744685

2032 年转印膜市场预测：按产品类型、转印方法、孔径、应用、最终用户和地区进行的全球分析

Transfer Membrane Market Forecasts to 2032 - Global Analysis By Product Type, Transfer Method, Pore Size, Application, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3个工作天内

价格

根据 Stratistics MRC 的数据，全球转移膜市场预计在 2025 年达到 4.612 亿美元，到 2032 年将达到 7.027 亿美元，预测期内的复合年增长率为 6.2%。

转膜是一种特殊的多孔材料，用于分子生物学和生物化学，将蛋白质和核酸等生物分子从凝胶转移到撑体上进行分析。它们通常由硝酸纤维素或聚二氟亚乙烯(PVDF) 製成，可在西方印渍术和南方印迹等技术中确保目标分子的有效结合和保留。它们对生物分子的高亲和性使其能够在研究和诊断应用中实现精确的检测、定量和表征。

根据欧盟委员会2022年12月更新的工业研发投资预测，预计美国2022年在研发上的支出将超过6,790亿美元。预计中国2022年在研发上的支出约为5,511亿美元。

增加生命科学研究资金

各国政府和私人机构正大力投资生技和分子诊断，推动膜技术的进步。资金的激增支持了西方印渍术和核酸分析等创新应用的开发，从而提高了研究效率。此外，製药和生物製药公司正在扩大研发力度，进一步推动了对高性能转膜的需求。因此，在持续的科学探索和技术改进的推动下，市场正在稳步成长。

膜选择和客製化的复杂性

研究人员必须仔细评估膜的特性，例如孔径、结合亲和性以及与检测方法的兼容性，以确保最佳性能。多种膜类型（例如硝酸纤维素、PVDF 和尼龙）的出现增加了复杂性，需要专业知识才能进行选择。此外，客製化需要精确的製造步骤，这会增加生产成本和时间。这些因素对新进者构成了障碍，延迟了采购决策，并影响了市场扩张。

新型薄膜材料的开发

聚合物科学和奈米技术的进步使得我们能够製造出灵敏度、耐久性和特异性更高的薄膜。研究人员正在探索生物工程膜，以提高蛋白质和核酸的转移效率，以满足不断发展的实验室需求。此外，永续性方面的担忧也推动了对环保膜替代品的需求，促使製造商进行创新，这些创新有望重塑产业格局。

替代分析技术的快速进步

微射流、数位PCR和自动化成像系统等新技术正在减少对传统膜基检测方法的依赖。这些替代技术具有更高的准确性、更快的处理速度和更少的样品消费量，因此对研究人员极具吸引力。随着实验室朝向更自动化和整合的工作流程迈进，对传统转膜的需求可能会减少。

COVID-19的影响：

新冠疫情对转膜市场的影响良莠不齐，既影响了供应链，也影响了研究重点。製造和物流中断导致供不应求，而对分子诊断和感染疾病研究的关注度增加则增加了膜需求。此外，疫情凸显了高效生物分子转膜的重要性，刺激了对高品质膜的投资。

尼龙转膜市场预计将成为预测期内最大的市场

尼龙膜凭藉其优异的耐用性和强大的结合力，预计将在预测期内占据最大的市场占有率。尼龙膜能够有效保留蛋白质，非常适合蛋白质西方印渍术等应用。其对多种检测技术的适应性增强了效用。此外，其高效的生物分子转移能力以及与先进染色方法的兼容性也是尼龙膜备受青睐的原因。

预计半干电转印领域在预测期内将以最高的复合年增长率成长。

半干电转印技术因其高通量和极低的缓衝液消耗，预计将在预测期内实现最高成长率。该技术因其能够缩短转印时间并确保分子的稳定保留而备受青睐。随着对经济高效且快速印迹解决方案的需求日益增长，实验室正在转向半干法以简化工作流程。

比最大的地区

在预测期内，北美预计将占据最大的市场占有率，推动了对高品质膜的持续需求。

复合年增长率最高的地区：

预计亚太地区将在预测期内呈现最高的复合年增长率。这得归功于医疗保健投资的增加以及分子​​分析技术的日益普及。中国和印度等国家正大力提升其科学研究能力，从而推动了对转膜的需求成长。人们对先进诊断工具的认识不断提高，以及政府旨在加强生命科学基础设施的倡议，也推动了市场的快速成长。

免费客製化服务：

订阅此报告的客户可以选择以下免费自订选项之一：

  • 公司简介
    • 对其他市场公司（最多 3 家公司）进行全面分析
    • 主要企业的SWOT分析（最多3家公司）
  • 地理细分
    • 根据客户兴趣对主要国家市场进行估计、预测和复合年增长率（註：基于可行性检查）
  • 竞争基准化分析
    • 根据产品系列、地理分布和策略联盟对主要企业基准化分析

目录

第一章执行摘要

第二章 前言

  • 概述
  • 相关利益者
  • 研究范围
  • 调查方法
    • 资料探勘
    • 数据分析
    • 数据检验
    • 研究途径
  • 研究材料
    • 主要研究资料
    • 次级研究资讯来源
    • 先决条件

第三章市场走势分析

  • 驱动程式
  • 限制因素
  • 机会
  • 威胁
  • 产品分析
  • 应用分析
  • 最终用户分析
  • 新兴市场
  • COVID-19的影响

第四章 波特五力分析

  • 供应商的议价能力
  • 买家的议价能力
  • 替代品的威胁
  • 新进入者的威胁
  • 竞争对手之间的竞争

第五章全球转印膜市场（依产品类型）

  • 硝酸纤维素转移膜
  • 聚二氟亚乙烯（PVDF）转印膜
  • 尼龙转移膜
  • 其他产品类型

6. 全球转印膜市场（按转印方式）

  • 湿式或槽式电转印
  • 半干式电转
  • 干电转

7. 全球膜运输市场（依孔径）

  • 小于0.2微米
  • 0.2～0.45um
  • 0.45um以上

第八章全球转印膜市场（按应用）

  • 西方印渍术
  • 南方印迹法
  • 北方印迹法
  • 蛋白质序列分析与胺基酸分析
  • 点/槽印迹法
  • 免疫印迹
  • 其他用途

第九章全球转印膜市场（依最终用户）

  • 学术研究所
  • 製药和生物技术公司
  • 诊断实验室
  • 合约开发和製造组织（CDMO）
  • 合约研究组织（CRO）
  • 其他最终用户

第 10 章全球转印膜市场（按区域）

  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 义大利
    • 法国
    • 西班牙
    • 其他欧洲国家
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 纽西兰
    • 韩国
    • 其他亚太地区
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地区
  • 中东和非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 卡达
    • 南非
    • 其他中东和非洲地区

第十一章 重大进展

  • 协议、伙伴关係、合作和合资企业
  • 收购与合併
  • 新产品发布
  • 业务扩展
  • 其他关键策略

第十二章 公司概况

  • Abcam
  • Advansta
  • ATTO Corporation
  • Azure Biosystems
  • Bio-Rad Laboratories
  • Carl Roth
  • Cytiva
  • GE Healthcare
  • Merck
  • Neogen Corporation
  • Pall Corporation
  • PerkinElmer
  • Roche Diagnostics
  • Santa Cruz Biotechnology Inc.
  • Sartorius AG
  • Thermo Fisher Scientific
  • MilliporeSigma
Product Code: SMRC29733

According to Stratistics MRC, the Global Transfer Membrane Market is accounted for $461.2 million in 2025 and is expected to reach $702.7 million by 2032 growing at a CAGR of 6.2% during the forecast period. Transfer membrane is a specialized porous material used in molecular biology and biochemistry to facilitate the transfer of biomolecules, such as proteins or nucleic acids, from a gel onto a solid support for analysis. Typically composed of nitrocellulose or polyvinylidene fluoride (PVDF), it ensures efficient binding and retention of target molecules during techniques like Western blotting or Southern blotting. Its high affinity for biomolecules enables precise detection, quantification, and characterization in research and diagnostic applications

According to the European Commission Industrial R&D Investment prediction, data updated in December 2022, the United States planned to spend more than USD 679 billion on research and development in 2022. It was anticipated that China would spend roughly USD 551.1 billion on R&D in 2022.

Market Dynamics:

Driver:

Increasing funding for life sciences research

Governments and private institutions are investing heavily in biotechnology and molecular diagnostics, leading to advancements in membrane technologies. This surge in funding supports the development of innovative applications such as Western blotting and nucleic acid analysis, enhancing research efficiency. Additionally, pharmaceutical and biopharmaceutical companies are expanding their R&D efforts, further boosting demand for high-performance transfer membranes. As a result, the market is witnessing steady growth, fueled by continuous scientific exploration and technological improvements.

Restraint:

Complexity of membrane selection and customization

Researchers must carefully evaluate membrane properties, including pore size, binding affinity, and compatibility with detection methods, to ensure optimal performance. The availability of multiple membrane types, such as nitrocellulose, PVDF, and nylon, adds to the complexity, requiring specialized knowledge for selection. Additionally, customization demands precise manufacturing processes, increasing production costs and time. These factors create barriers for new entrants and slow down procurement decisions, impacting market expansion.

Opportunity:

Development of novel membrane materials

Advances in polymer science and nanotechnology are enabling the creation of membranes with enhanced sensitivity, durability, and specificity. Researchers are exploring bioengineered membranes that improve protein and nucleic acid transfer efficiency, catering to evolving laboratory needs. Additionally, sustainability concerns are driving the demand for eco-friendly membrane alternatives, encouraging manufacturers to innovate expected to reshape the industry landscape.

Threat:

Rapid advancements in alternative analytical techniques

Emerging technologies such as microfluidics, digital PCR, and automated imaging systems are reducing reliance on traditional membrane-based assays. These alternatives offer higher precision, faster processing times, and reduced sample consumption, making them attractive to researchers. As laboratories transition to more automated and integrated workflows, the demand for conventional transfer membranes may decline.

Covid-19 Impact:

The COVID-19 pandemic had a mixed impact on the transfer membrane market, influencing both supply chains and research priorities. While disruptions in manufacturing and logistics led to temporary shortages, the heightened focus on molecular diagnostics and infectious disease research increased demand for membranes. Additionally, the pandemic underscored the importance of efficient biomolecule transfer, prompting investments in high-quality membranes.

The nylon transfer membranes segment is expected to be the largest during the forecast period

The nylon transfer membranes segment is expected to account for the largest market share during the forecast period due to its exceptional durability and strong binding capacity. Nylon membranes effectively retain proteins, making them highly suitable for applications such as Western blotting. Their adaptability across multiple detection techniques enhances their utility in research settings. Additionally, their efficiency in biomolecule transfer and compatibility with advanced staining methods contribute to their growing preference.

The semi-dry electrotransfer segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the semi-dry electrotransfer segment is predicted to witness the highest growth rate driven by its rapid processing capabilities and minimal buffer consumption. This technique is favored for its ability to accelerate transfer time while ensuring consistent molecular retention. With increasing demand for cost-effective and high-speed blotting solutions, laboratories are shifting toward semi-dry methods to streamline workflows.

Region with largest share:

During the forecast period, the North America region is expected to hold the largest market share due to its well-established biotechnology infrastructure and robust investments in life sciences research. The presence of leading pharmaceutical companies and advanced research institutions fosters continual innovation in transfer membrane applications. Additionally, strong government funding for molecular diagnostics and proteomics research reinforces the region's market leadership, driving sustained demand for high-quality membranes.

Region with highest CAGR:

Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR supported by rising healthcare investments and growing adoption of molecular analysis techniques. Countries like China and India are significantly expanding their research capabilities, fostering greater demand for transfer membranes. Increasing awareness of advanced diagnostic tools and government initiatives aimed at strengthening life sciences infrastructure are contributing to rapid market growth

Key players in the market

Some of the key players in Transfer Membrane Market include Abcam, Advansta, ATTO Corporation, Azure Biosystems, Bio-Rad Laboratories, Carl Roth, Cytiva, GE Healthcare, Merck, Neogen Corporation, Pall Corporation, PerkinElmer, Roche Diagnostics, Santa Cruz Biotechnology Inc., Sartorius AG, Thermo Fisher Scientific and MilliporeSigma.

Key Developments:

In May 2025, Roche Diagnostics announced a strategic collaboration with Broad Clinical Labs to develop applications using Roche's SBX sequencing technology. The partnership aims to accelerate the adoption of cutting-edge sequencing solutions in clinical genomics.

In April 2025, Merck entered into a definitive agreement to acquire SpringWorks Therapeutics, a U.S. biopharmaceutical company. The acquisition aims to accelerate Merck's growth in the healthcare sector.

In March 2025, GE Healthcare announced the U.S. launch of Flyrcado, a unit dose PET myocardial perfusion imaging agent. Flyrcado aims to enhance cardiac imaging by providing improved diagnostic accuracy.

Product Types Covered:

  • Nitrocellulose Transfer Membranes
  • Polyvinylidene Fluoride (PVDF) Transfer Membranes
  • Nylon Transfer Membranes
  • Other Product Types

Transfer Methods Covered:

  • Wet or Tank Electrotransfer
  • Semi-Dry Electrotransfer
  • Dry Electrotransfer

Pore Sizes Covered:

  • <0.2 µm
  • 0.2-0.45 µm
  • >0.45 µm

Applications Covered:

  • Western Blotting
  • Southern Blotting
  • Northern Blotting
  • Protein Sequencing & Amino Acid Analysis
  • Dot/Slot Blotting
  • Immunoblotting
  • Other Applications

End Users Covered:

  • Academic & Research Institutions
  • Pharmaceutical & Biotechnology Companies
  • Diagnostic Laboratories
  • Contract Development & Manufacturing Organizations (CDMOs)
  • Contract Research Organizations (CROs)
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2024, 2025, 2026, 2028, and 2032
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 Application Analysis
  • 3.8 End User Analysis
  • 3.9 Emerging Markets
  • 3.10 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Transfer Membrane Market, By Product Type

  • 5.1 Introduction
  • 5.2 Nitrocellulose Transfer Membranes
  • 5.3 Polyvinylidene Fluoride (PVDF) Transfer Membranes
  • 5.4 Nylon Transfer Membranes
  • 5.5 Other Product Types

6 Global Transfer Membrane Market, By Transfer Method

  • 6.1 Introduction
  • 6.2 Wet or Tank Electrotransfer
  • 6.3 Semi-Dry Electrotransfer
  • 6.4 Dry Electrotransfer

7 Global Transfer Membrane Market, By Pore Size

  • 7.1 Introduction
  • 7.2 <0.2 µm
  • 7.3 0.2-0.45 µm
  • 7.4 >0.45 µm

8 Global Transfer Membrane Market, By Application

  • 8.1 Introduction
  • 8.2 Western Blotting
  • 8.3 Southern Blotting
  • 8.4 Northern Blotting
  • 8.5 Protein Sequencing & Amino Acid Analysis
  • 8.6 Dot/Slot Blotting
  • 8.7 Immunoblotting
  • 8.8 Other Applications

9 Global Transfer Membrane Market, By End User

  • 9.1 Introduction
  • 9.2 Academic & Research Institutions
  • 9.3 Pharmaceutical & Biotechnology Companies
  • 9.4 Diagnostic Laboratories
  • 9.5 Contract Development & Manufacturing Organizations (CDMOs)
  • 9.6 Contract Research Organizations (CROs)
  • 9.7 Other End Users

10 Global Transfer Membrane Market, By Geography

  • 10.1 Introduction
  • 10.2 North America
    • 10.2.1 US
    • 10.2.2 Canada
    • 10.2.3 Mexico
  • 10.3 Europe
    • 10.3.1 Germany
    • 10.3.2 UK
    • 10.3.3 Italy
    • 10.3.4 France
    • 10.3.5 Spain
    • 10.3.6 Rest of Europe
  • 10.4 Asia Pacific
    • 10.4.1 Japan
    • 10.4.2 China
    • 10.4.3 India
    • 10.4.4 Australia
    • 10.4.5 New Zealand
    • 10.4.6 South Korea
    • 10.4.7 Rest of Asia Pacific
  • 10.5 South America
    • 10.5.1 Argentina
    • 10.5.2 Brazil
    • 10.5.3 Chile
    • 10.5.4 Rest of South America
  • 10.6 Middle East & Africa
    • 10.6.1 Saudi Arabia
    • 10.6.2 UAE
    • 10.6.3 Qatar
    • 10.6.4 South Africa
    • 10.6.5 Rest of Middle East & Africa

11 Key Developments

  • 11.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 11.2 Acquisitions & Mergers
  • 11.3 New Product Launch
  • 11.4 Expansions
  • 11.5 Other Key Strategies

12 Company Profiling

  • 12.1 Abcam
  • 12.2 Advansta
  • 12.3 ATTO Corporation
  • 12.4 Azure Biosystems
  • 12.5 Bio-Rad Laboratories
  • 12.6 Carl Roth
  • 12.7 Cytiva
  • 12.8 GE Healthcare
  • 12.9 Merck
  • 12.10 Neogen Corporation
  • 12.11 Pall Corporation
  • 12.12 PerkinElmer
  • 12.13 Roche Diagnostics
  • 12.14 Santa Cruz Biotechnology Inc.
  • 12.15 Sartorius AG
  • 12.16 Thermo Fisher Scientific
  • 12.17 MilliporeSigma

List of Tables

  • Table 1 Global Transfer Membrane Market Outlook, By Region (2024-2032) ($MN)
  • Table 2 Global Transfer Membrane Market Outlook, By Product Type (2024-2032) ($MN)
  • Table 3 Global Transfer Membrane Market Outlook, By Nitrocellulose Transfer Membranes (2024-2032) ($MN)
  • Table 4 Global Transfer Membrane Market Outlook, By Polyvinylidene Fluoride (PVDF) Transfer Membranes (2024-2032) ($MN)
  • Table 5 Global Transfer Membrane Market Outlook, By Nylon Transfer Membranes (2024-2032) ($MN)
  • Table 6 Global Transfer Membrane Market Outlook, By Other Product Types (2024-2032) ($MN)
  • Table 7 Global Transfer Membrane Market Outlook, By Transfer Method (2024-2032) ($MN)
  • Table 8 Global Transfer Membrane Market Outlook, By Wet or Tank Electrotransfer (2024-2032) ($MN)
  • Table 9 Global Transfer Membrane Market Outlook, By Semi-Dry Electrotransfer (2024-2032) ($MN)
  • Table 10 Global Transfer Membrane Market Outlook, By Dry Electrotransfer (2024-2032) ($MN)
  • Table 11 Global Transfer Membrane Market Outlook, By Pore Size (2024-2032) ($MN)
  • Table 12 Global Transfer Membrane Market Outlook, By <0.2 µm (2024-2032) ($MN)
  • Table 13 Global Transfer Membrane Market Outlook, By 0.2-0.45 µm (2024-2032) ($MN)
  • Table 14 Global Transfer Membrane Market Outlook, By >0.45 µm (2024-2032) ($MN)
  • Table 15 Global Transfer Membrane Market Outlook, By Application (2024-2032) ($MN)
  • Table 16 Global Transfer Membrane Market Outlook, By Western Blotting (2024-2032) ($MN)
  • Table 17 Global Transfer Membrane Market Outlook, By Southern Blotting (2024-2032) ($MN)
  • Table 18 Global Transfer Membrane Market Outlook, By Northern Blotting (2024-2032) ($MN)
  • Table 19 Global Transfer Membrane Market Outlook, By Protein Sequencing & Amino Acid Analysis (2024-2032) ($MN)
  • Table 20 Global Transfer Membrane Market Outlook, By Dot/Slot Blotting (2024-2032) ($MN)
  • Table 21 Global Transfer Membrane Market Outlook, By Immunoblotting (2024-2032) ($MN)
  • Table 22 Global Transfer Membrane Market Outlook, By Other Applications (2024-2032) ($MN)
  • Table 23 Global Transfer Membrane Market Outlook, By End User (2024-2032) ($MN)
  • Table 24 Global Transfer Membrane Market Outlook, By Academic & Research Institutions (2024-2032) ($MN)
  • Table 25 Global Transfer Membrane Market Outlook, By Pharmaceutical & Biotechnology Companies (2024-2032) ($MN)
  • Table 26 Global Transfer Membrane Market Outlook, By Diagnostic Laboratories (2024-2032) ($MN)
  • Table 27 Global Transfer Membrane Market Outlook, By Contract Development & Manufacturing Organizations (CDMOs) (2024-2032) ($MN)
  • Table 28 Global Transfer Membrane Market Outlook, By Contract Research Organizations (CROs) (2024-2032) ($MN)
  • Table 29 Global Transfer Membrane Market Outlook, By Other End Users (2024-2032) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.